1,096
Views
2
CrossRef citations to date
0
Altmetric
Research Article

A new maximal bicycle test using a prediction algorithm developed from four large COPD studies

, , , , , , , , & show all
Article: 1692645 | Received 12 Aug 2019, Accepted 08 Nov 2019, Published online: 20 Nov 2019

References

  • Chawla H, Bulathsinghala C, Tejada JP, et al. Physical activity as a predictor of thirty-day hospital readmission after a discharge for a clinical exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(8):1203–10.
  • Iyer AS, Wells JM, Bhatt SP, et al. Life-space mobility and clinical outcomes in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:2731–2738.
  • Marin JM, Alfageme I, Almagro P, et al. Multicomponent indices to predict survival in COPD: the COCOMICS study. Eur Respir J. 2013;42(2):323–332.
  • Marin JM, Carrizo SJ, Casanova C, et al. Prediction of risk of COPD exacerbations by the BODE index. Respir Med. 2009;103(3):373–378.
  • Moy ML, Teylan M, Weston NA, et al. Daily step count predicts acute exacerbations in a US cohort with COPD. PLoS One. 2013;8(4):e60400.
  • Rodriguez DA, Kortianou EA, Alison JA, et al. Heart rate recovery after 6-min walking test predicts acute exacerbation in COPD. Lung. 2017;195(4):463–467.
  • Palange P, Ward SA, Carlsen KH, et al. ERS task force.recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007;29(1):185–209.
  • American Thoracic Society. American College of Chest P. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–277.
  • O’Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1557–1565.
  • Puente-Maestu L, Palange P, Casaburi R, et al. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J. 2016;47(2):429–460.
  • Singh S, Harvey-Dunstan TC. Walking for the assessment of patients with COPD. In: Palange P, Laveneziana P, Neder JA, et al., editors. Clinical exercise testing (ERS monograph). Sheffield: European Respiratory Society; 2018. p. 175–195.
  • Magnussen H, Paggiaro P, Schmidt H, et al. Effect of combination treatment on lung volumes and exercise endurance time in COPD. Respir Med. 2012;106(10):1413–1420.
  • Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest. 2005;128(3):1168–1178.
  • Cahalin L, Pappagianopoulos P, Prevost S, et al. The relationship of the 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease. Chest. 1995;108(2):452–459.
  • Carter R, Holiday DB, Stocks J, et al. Predicting oxygen uptake for men and women with moderate to severe chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2003;84(8):1158–1164.
  • Hartman JE, Slebos DJ, Boezen HM, et al. Selecting the increment size for a maximal incremental cycle test in patients with COPD. Respirology. 2015;20(2):352–355.
  • Inal-Ince D, Savci S, Coplu L, et al. Functional capacity in severe chronic obstructive pulmonary disease. Saudi Med J. 2005;26(1):84–89.
  • Carter R, Peavler M, Zinkgraf S, et al. Predicting maximal exercise ventilation in patients with chronic obstructive pulmonary disease. Chest. 1987;92(2):253–259.
  • LoRusso TJ, Belman MJ, Elashoff JD, et al. Prediction of maximal exercise capacity in obstructive and restrictive pulmonary disease. Chest. 1993;104(6):1748–1754.
  • Behnia M, Wheatley C, Avolio A, et al. Influence of resting lung diffusion on exercise capacity in patients with COPD. BMC Pulm Med. 2017;17(1):117.
  • Efremidis G, Tsiamita M, Manolis A, et al. Accuracy of pulmonary function tests in predicted exercise capacity in COPD patients. Respir Med. 2005;99(5):609–614.
  • Chuang ML, Lin IF, Vintch JR. Comparison of estimated and measured maximal oxygen uptake during exercise testing in patients with chronic obstructive pulmonary disease. Intern Med J. 2004;34(8):469–474.
  • Coquart JB, Eston RG, Lemaitre F, et al. Prediction of peak oxygen uptake from ratings of perceived exertion during a sub-maximal cardiopulmonary exercise test in patients with chronic obstructive pulmonary disease. Eur J Appl Physiol. 2015;115(2):365–372.
  • Ekblom-Bak E, Bjorkman F, Hellenius ML, et al. A new submaximal cycle ergometer test for prediction of VO2max. Scand J Med Sci Sports. 2014;24(2):319–326.
  • Cavalheri V, Hernandes NA, Camillo CA, et al. Estimation of maximal work rate based on the 6-minute walk test and fat-free mass in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2010;91(10):1626–1628.
  • Fregonezi G, Resqueti V, Vigil L, et al. Maximal oxygen uptake cannot be estimated from resting lung function and submaximal exercise in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2012;32(4):219–225.
  • Buchfuhrer MJ, Hansen JE, Robinson TE, et al. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol Respir Environ Exerc Physiol. 1983;55(5):1558–1564.
  • Debigare R, Maltais F, Mallet M, et al. Influence of work rate incremental rate on the exercise responses in patients with COPD. Med Sci Sports Exerc. 2000;32(8):1365–1368.
  • O’Donnell DE, Maltais F, Porszasz J, et al. The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trial. PLoS One. 2014;9(5):e96574.
  • Worth H, Forster K, Eriksson G, et al. Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. Respir Med. 2010;104(10):1450–1459.
  • Couronne R, Probst P, Boulesteix AL. Random forest versus logistic regression: a large-scale benchmark experiment. BMC Bioinformatics. 2018;19(1):270.
  • Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–381.
  • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–310.
  • Hegewald MJ, Markewitz BA, Wilson EL, et al. Single-breath diffusing capacity for carbon monoxide instrument accuracy across 3 health systems. Respir Care. 2015;60(3):430–436.
  • Eriksson G, Jarenback L, Peterson S, et al. A new approach to assess COPD by identifying lung function break-points. Int J Chron Obstruct Pulmon Dis. 2015;10:2193–2202.